Kallyope Receives $44,000,000 Series A Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2725de03-08d8-4e93-89df-5207b0cf3df3 - Date
12/11/2015 - Company Name
Kallyope - Mailing Address
430 East 29th Street 8th Floor New York, NY 10016 USA - Company Description
At Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the gut informs our brains about our well-being, metabolism, and nutritional state. - Website
http://www.kallyope.com - Transaction Type
Venture Equity - Transaction Amount
$44,000,000 - Transaction Round
Series A - Proceeds Purposes
Kallyope will leverage cutting edge technologies including sequencing, genetics, circuit mapping, neural imaging and bioinformatics. - M&A Terms
- Venture Investor
Lux Capital - Venture Investor
Polaris Partners - Venture Investor
The Column Group - Venture Investor
Illumina Accelerator Program - Venture Investor
Alexandria Venture Investments
